More PRNewswire
View Older Stories View Newer Stories-
Sunraycer Renewables Closes $901 Million Project Financing Facility with MUFG Bank, Ltd., Ally Bank, Nomura Securities International, Inc., Norddeutsche Landesbank Girozentrale, and Societe Generale
-
CREATE Medicines Announces $122 Million Series B Financing to Advance In Vivo CAR Pipeline in Autoimmune Disease and Oncology
-
Ally unveils "Life Today," putting customers at the center of where life and money collide
-
Rockwell Automation Expands EtherNet/IP In-cabinet Solution with New Motor Control and Power Connection Capabilities
-
TACO BELL® SERVES UP A CANTINA CHICKEN TWIST ON ITS ICONIC MEXICAN PIZZA
-
OLE SMOKY DISTILLERY AND YEE-HAW BREWING CO. TO OPEN JOINT SOUTH CAROLINA LOCATION IN MYRTLE BEACH
-
MEDIPOST's CARTISTEM® Meets All Primary and Secondary Endpoints in Japan Phase 3 Trial and Demonstrates Statistically Significant Efficacy Gains Versus Active Control
-
CrossCountry Mortgage to Provide Additional Cash Value to Two Harbors Stockholders
-
Contango Announces Results for the Quarter Ended March 31, 2026
-
Flagship Mazda Expands Access to New Hybrid and Plug-In Hybrid Models in San Juan, PR
-
SBC, IAGR & IMGL combine for three-year regulatory education project
-
New Tokens Average at 2,341%, TradFi Futures Volume Climbs 55%: MEXC April Report
-
Allegheny Health Network's Cardiovascular Institute Sees Positive Outcomes from Groundbreaking Therapy for Treatment-Resistant Hypertension
-
Delta Beverages Contributes to National Advocacy Effort Supporting Hemp Beverage Regulation
-
Nova Reports Record First Quarter 2026 Financial Results
-
DeFi Technologies Appoints Russell Starr as Strategic Advisor
-
Optura Secures $17.5 Million Series A from Salesforce Ventures and Echo Health Ventures to Scale its ROAI™ Platform
-
Galmed Announces Results from First-in-Man Pharmacokinetics Study of Oral Formulation of Aramchol Meglumine (AM); 400mg AM Increases Bioavailability by ~500% in Comparison to Aramchol Free Acid (AA) 3
-
MOHEGAN ANNOUNCES SECOND QUARTER FISCAL 2026 OPERATING RESULTS
-
Wingstop Debuts 'House of Flavor' Fan Experience in North America for the First Time
-
Nyra Medical to Highlight First-in-Human Clinical Insights Through Three Presentations at EuroPCR
-
Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment
-
Cardiol Therapeutics to Participate in Fireside Chat at H.C. Wainwright 4th Annual BioConnect Investor Conference at the NASDAQ
-
aiMotive announces aiWare5, delivering unrivalled flexibility and scalability for L2+ to L4 automotive AI workloads
-
Resurge Therapeutics Announces Positive Clinical Results from Two Studies of Its Intraprostatic Drug Elution Platform for Benign Prostatic Hyperplasia (BPH) at AUA 2026
-
Former Meta Executive Bar Clara Mendez McConnon Appointed CEO and Managing Partner of Value Gateway Capital Partners
-
Mill Creek Receives Full Approvals for Proposed Multifamily Community in Marin County
-
Bolding Family Dentistry in Columbia, TN Announces New Website and Continued Patient Care Under Dr. Beau Bolding
-
Healthcare Triangle Reports 627% Increase in Gross Profit and 166% Increase in Revenue for Q1 2026
-
REGENXBIO Reports First Quarter 2026 Financial Results and Operational Highlights
-
Rochefort Provides Financing to Red 6 to Expand Military Augmented Reality Training
-
VARON Celebrates Older Americans Month by Supporting Healthy Aging and Independence
-
Monport Marks Memorial Day With Savings on Laser Engraving Machines and Creative Tools
-
Women in HVACR announces keynote speakers for its 2026 annual conference
-
Cypherpunk Technologies Reports First Quarter 2026 Financial Results
-
Veeva Commercial Summit to Feature Biopharma's AI Successes and the Path to Agentic Commercial
-
Animal Rescues Corps assists in Louisiana animal cruelty case
-
Iridium to Acquire Aireon, Advancing its Strategy to Lead the Future of Aviation Safety
-
REGENXBIO Announces Positive Topline Results from Pivotal Phase III AFFINITY DUCHENNE® Study of RGX-202
-
Mezzion Secures Strategic Financing to Support Advancement of Global Phase 3 FUEL-2 Trial in Fontan Patients
-
Anduril Industries Named Flagship Sponsor of BlueTIDE 2026
-
bidadoo Reports Robust Q1 2026 Growth as Online Equipment Remarketing Demand Surges
-
BCE to participate in the J.P. Morgan 2026 Global Technology, Media and Communications Conference in Boston
-
Innoviz Reports First Quarter 2026 Results
-
CryptoSlots Celebrates 8th Birthday with VR Slots, New Game Launches and Month-Long Promotions
-
Fermi Inc. Outlines Fermi 2.0 Strategic Evolution and Reports First Quarter 2026 Financial Results
-
URBAN ONE, INC. REPORTS FIRST QUARTER 2026 RESULTS
-
NG ENERGY ANNOUNCES FILING OF Q1 2026 FINANCIAL RESULTS
-
Signant Health Acquires Ametris to Create an End-to-End eCOA and Digital Outcome Measures Platform
-
GEMMABio Unveils Duchenne Muscular Dystrophy (DMD) Program and Presents Preclinical Data for Next‑Generation Gene Therapies for DMD and Spinal Muscular Atrophy Type 1 (SMA1) at the ASGCT 2026 Annual
